Showing results (101-110 of 413) with videos related to
Sort By:
Pageof 42
Molecular & Cellular Proteomics : MCP|November 15, 2008
Urine metabolomics analysis for kidney cancer detection and biomarker discoveryKyoungmi Kim, Pavel Aronov, Stanislav O Zakharkin, et al.The Journal of Urology|June 14, 2008
Total prostate specific antigen stability confirmed after long-term storage of serum at -80CAmanda Beth Reed, Donna Pauler Ankerst, Robin J Leach, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical TrialsCatherine M Tangen, Phyllis J Goodman, Cathee Till, et al.Annals of Translational Medicine & Epidemiology|January 27, 2015
Statins and Finasteride Use Differentially Modify the Impact of Metformin on Prostate Cancer Incidence in Men with Type 2 DiabetesWang Chen-Pin, Hernandez Javier, Carlos Lorenzo, et al.The Prostate|January 1, 2008
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatmentYoonJu Song, Catherine Tangen, Phyllis Goodman, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approachMary W Redman, Catherine M Tangen, Phyllis J Goodman, et al.Hematology/Oncology Clinics of North America|July 25, 2006
Chemoprevention of prostate cancerTimothy C Brand, Edith D Canby-Hagino, A Pratap Kumar, et al.The Journal of Urology|May 16, 2006
The prostate cancer prevention trial: design, biases and interpretation of study resultsPhyllis J Goodman, Ian M Thompson, Catherine M Tangen, et al.Clinical Prostate Cancer|March 30, 2004
Ten-year survival in patients with metastatic prostate cancerCatherine M Tangen, James R Faulkner, E David Crawford, et al.Urologia Internationalis|May 26, 2012
The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation studyYuanyuan Liang, Norma S Ketchum, Christopher Louden, et al.Pageof 42